Table 4. Antimicrobial IZ in mm ± Standard Deviation of Synthesized Compounds.
| diameter
of the IZ (mm) |
||||||
|---|---|---|---|---|---|---|
| Gram
(−ve) bacteria |
Gram
(+ve) bacteria |
fungi | ||||
| compd no. | E. coli (ATCC:3008) | K. pneumonia (ATCC:4415) | P. aeruginosa (ATCC:27853) | S. aureus (ATCC:6538) | S. mutans (ATCC:25175) | C. albicans (ATCC:10231) |
| 3b | a | |||||
| 8a | 19.0 ± 0.5 | 25.8 ± 0.5 | 19.8 ± 1.0 | |||
| 8b | 32.2 ± 2.5 | 19.3 ± 1.0 | 10.7 ± 0.5 | |||
| 8c | 24.5 ± 0.7 | 21.3 ± 1.1 | ||||
| 8d | 29.9 ± 0.6 | 12.5 ± 1.0 | ||||
| 9a | 34.0 ± 1.0 | 13.9 ± 0.5 | ||||
| 9b | 15.0 ± 0.5 | 21.3 ± 1.0 | 24.3 ± 0.5 | |||
| 13a | 30.0 ± 1.0 | 22.0 ± 0.5 | ||||
| 13b | 28.9 ± 0.7 | 21.0 ± 0.1 | ||||
| 15a | 19.6 ± 2.0 | |||||
| 15b | ||||||
| 15c | ||||||
| 15d | 19.6 ± 1.5 | 35.3 ± 1.5 | 11.3 ± 1.1 | 9.0 ± 1.0 | ||
| gentamicin | 25.0 ± 0.1 | 32.0 ± 0.1 | 35.0 ± 0.1 | NT | NT | NT |
| ampicillin | NTb | NT | NT | 32.0 ± 0.5 | 22.0 ± 0.5 | NT |
| nystatin | NT | NT | NT | NT | NT | 28.0 ± 0.2 |
| sulfadiazine | 19.8 ± 0.4 | 20.4 ± 0.9 | 24.0 ± 1.4 | 31.3 ± 2.1 | 16.3 ± 1.1 | NA |
a
No activity.
b
Not tested.